Discover a study that highlights the importance of identifying high-risk children through biomarkers and better understanding ...

RSV infections in children needing primary care cause high economic impact due to outpatient costs and parental work absences ...

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections in infants ...

Respiratory Syncytial Virus (RSV) poses a significant threat to Indian infants, particularly during post-monsoon and winter, ...

with nearly all children experiencing at least one RSV infection by the age of 2. While some children develop a severe form of RSV disease that might require hospitalization, most infections are ...

RSV causes about 100,000 deaths and more than 3.6 million hospitalisations in children under the age of 5 worldwide ...

“I had actually only heard of RSV in passing conversation. I hadn't actually looked after anyone with RSV,” she explained.

On June 2, 2025, Southeast Asia and India marked a historic milestone in the fight against respiratory syncytial virus (RSV), ...

More than 22,000 newborn babies received immunisation against RSV this winter as part of a pilot HSE programme to combat the ...

Kolkata: A seven-month-old baby was among the 60 fresh Covid-positive cases reported in Bengal on Wednesday. The infant, ...